AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18559233
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese drug (TCD) treatment with Huzhang Gout Granule and Jinhuang Ointment in acute stage; Yinlian Gout Granule in intermission.
Trial: 18559233
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (WM) treatment with diclofenac sodium dual release enteric-coated capsules in acute stage; benzbromarone or allopurinol in intermission.
Trial: 18559233
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of TCD and WM treatment in acute stage and intermission.
Trial: 18559233
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not specified, but implied as no treatment).
Trial: 15612981
Drug: Basiliximab (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basiliximab (20 mg if body weight >30 kg; 10 mg if <30 kg) given pretransplant and at day 4; Tacrolimus (Tac) administered to obtain blood trough levels of 10-20 ng/ml during the first 2 months and 5-10 ng/ml thereafter; Steroids tapered during the first 6 months and replaced by mycophenolate mofetil (4-600 mg/m² body surface area) depending on previous rejection episodes, infection status, and routine biopsy results.
Trial: 11422684
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of palpatory tenderness and clenching habit
Trial: 8996129
Drug: Ketamine-midazolam (KM):
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine-midazolam (KM): atropine 0.01 mg/kg, midazolam 0.05 mg/kg, ketamine 1.5 mg/kg
Trial: 8996129
Drug: Meperidine-midazolam (MM):
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine-midazolam (MM): meperidine 2 mg/kg, midazolam 0.1 mg/kg
Trial: 7912103
Drug: Intravenous mivazerol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous mivazerol 1 microgram/kg
Trial: 7912103
Drug: Intravenous mivazerol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous mivazerol 2 micrograms/kg
Trial: 7912103
Drug: Intravenous mivazerol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous mivazerol 3 micrograms/kg
Trial: 7912103
Drug: Oral mivazerol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral mivazerol 800 micrograms
Trial: 7912103
Drug: Oral mivazerol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral mivazerol 1200 micrograms
Trial: 7912103
Drug: Oral mivazerol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral mivazerol 1600 micrograms
Trial: 3520390
Drug: Aminophylline and
RxNorm normalized name: aminophylline and adrenergics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline and clenbuterol combination
Trial: 31910393
Drug: Inspiratory Muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inspiratory Muscle Training (IMT) for 8 weeks, 7 days per week, twice daily, using POWERbreathe KH1, starting at 50% of maximum inspiratory pressure with progressively increasing load
Trial: 24958577
Drug: RDR and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RDR and PD20FEV1 combination
Trial: 20546210
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of sufentanil with ropivacaine
Trial: 18262758
Drug: Medroxyprogesterone acetate/megestrol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate/megestrol acetate plus pharmacologic nutritional support plus L-carnitine plus thalidomide
Trial: 12791112
Drug: Caudal analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal analgesia with 1.0 ml.kg‐1 body weight (BW) bupivacaine 0.25%
Trial: 12791112
Drug: Wound instillation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wound instillation with 0.2 ml.kg‐1 BW bupivacaine 0.5%
Trial: 8806245
Drug: ethamsylate 500
RxNorm normalized name: ethamsylate 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ethamsylate 500 mg six hourly
Trial: 8806245
Drug: mefenamic acid
RxNorm normalized name: Mefenamic Acid
DrugBank: Mefenamic acid (DB00784)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: mefenamic acid 500 mg eight hourly
Trial: 8806245
Drug: tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: tranexamic acid 1 g six hourly
Trial: 1459517
Drug: pirenzepine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pirenzepine (100 mg/day)
Trial: 1459517
Drug: pirenzepine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pirenzepine (75 mg/day)
Trial: 3901683
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose group (HDG) received 120‐160 mg furosemide daily for six weeks
Trial: 3901683
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose group (LDG) received 20‐40 mg furosemide daily for six weeks
Trial: 30920098
Drug: Intralesional injection
RxNorm normalized name: DEXAMETHASONE SODIUM PHOSPHATE 4 mg in 1 mL INTRALESIONAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional injection of 0.2 mL of vitamin D3 (300,000 IU) into the base of mother wart for two sessions
Trial: 27412942
Drug: Xinfeng capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xinfeng capsule (XFC), 3 capsules three times daily for 12 weeks
Trial: 27412942
Drug: Sulfasalazine (SASP),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfasalazine (SASP), 4 tablets two times daily for 12 weeks
Trial: 1596064
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of lidocaine
Trial: 22611998
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of lidocaine
Trial: 22611998
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg vs 200 mg lidocaine
Trial: 16095507
Drug: 15 mg/day
RxNorm normalized name: Climara Pro 0.045/0.015 MG/Day Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/day of 5‐methyl‐tetrahydrofolate
Trial: 10072746
Drug: Standard program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard program (including rectal examination, fecal occult blood testing, and flexible sigmoidoscopy)
Trial: 8533868
Drug: Neuroleptanaesthesia (NLA):
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroleptanaesthesia (NLA): 7.1 mg droperidol and 0.008 mg/kg body weight fentanyl
Trial: 8533868
Drug: Intravenous anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anaesthesia with propofol (IVA): 493.4 mg propofol and 0.004 mg/kg body weight fentanyl
Trial: 8533868
Drug: Balanced anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balanced anaesthesia (BAL): 2.6 mg droperidol and 0.004 mg/kg body weight fentanyl with 0.4 vol.% isoflurane
Trial: 2148278
Drug: Enoximone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoximone (2 X bolus 0.5 mg/kg; infusion 5.0 micrograms/kg/min)
Trial: 28527788
Drug: Game-based inhibition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Game-based inhibition training on a tablet for two months
Trial: 17329193
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy for SCC
Trial: 17329193
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy for adenocarcinoma
Trial: 8864327
Drug: Phenytoin alone
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenytoin alone (600 mg)
Trial: 8864327
Drug: Phenytoin with
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenytoin with atovaquone (600 mg phenytoin + 2000 mg atovaquone as two doses of 1000 mg)
Trial: 6868097
Drug: Syringe and
RxNorm normalized name: KIT, SYRINGE AND TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syringe and needle (0.5 ml)
Trial: 6868097
Drug: Jet-injector (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jet-injector (0.1 ml)
Trial: 6868097
Drug: Nose drops
RxNorm normalized name: Nose Drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nose drops (0.5 ml)
Trial: 30785053
Drug: Cognitive-Behavioral Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-Behavioral Therapy for Insomnia (CBTI)
Trial: 16172439
Drug: Specific program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific program administered by rheumatologists including education, protocol-based clinical management, and administrative duties.
Trial: 11840225
Drug: Sibutramine 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 20 mg once daily
Trial: 2403062
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg vitamin A preparation
Trial: 2403062
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg vitamin A preparation
Trial: 2403062
Drug: Placebo (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0 mg vitamin A preparation)
Trial: 30168905
Drug: TAK-117 tablet
RxNorm normalized name: TAK-243
DrugBank: TAK-243 (DB15013)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAK-117 tablet (900 mg)
Trial: 30168905
Drug: TAK-117 (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAK-117 (600 mg) under fed conditions (high-fat meal)
Trial: 30168905
Drug: TAK-117 (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAK-117 (900 mg) plus lansoprazole
Trial: 25318563
Drug: Standard HIV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard HIV testing and referral for treatment (control)
Trial: 22766124
Drug: Oral tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tramadol 50 mg capsules (n = 35)
Trial: 22766124
Drug: Naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen sodium 550 mg tablets (n = 34)
Trial: 17350802
Drug: Zinc (Zn)
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc (Zn) 0.59 mg as zinc sulfate with 0.5 mg Fe as ferrous sulfate
Trial: 17350802
Drug: Zinc (Zn)
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc (Zn) 11.71 mg as zinc sulfate with 10 mg Fe
Trial: 17350802
Drug: Iron (Fe)
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iron (Fe) 0.5 mg as ferrous sulfate alone
Trial: 17350802
Drug: Iron (Fe)
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iron (Fe) 10 mg alone
Trial: 12050912
Drug: Interferon (IFN)
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon (IFN) therapy (3 MU three times a week for 12 months)
Trial: 11512193
Drug: Professional oral
RxNorm normalized name: Dentek Professional Oral Care Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Professional oral hygiene and patient education in oral hygiene
Trial: 1981905
Drug: Lozenge containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lozenge containing 11 mg (-)-menthol
Trial: 1981905
Drug: Candy placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candy placebo lozenge
Trial: 23384256
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium infusion for 2 weeks followed by oral magnesium capsules for 4 weeks
Trial: 21841065
Drug: Sclerosing treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sclerosing treatment with polidocanol
Trial: 19214120
Drug: Nevirapine twice
RxNorm normalized name: Nevirapine
DrugBank: Nevirapine (DB00238)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nevirapine twice daily
Trial: 10579480
Drug: R116301 (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R116301 (300 mg, oral administration)
Trial: 1915428
Drug: Nicainoprol 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicainoprol 400 mg
Trial: 1915428
Drug: Nicainoprol 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicainoprol 600 mg
Trial: 1915428
Drug: Nicainoprol 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicainoprol 200 mg
Trial: 31409515
Drug: High-dose rosuvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose rosuvastatin (40 mg/day)
Trial: 31409515
Drug: Low-dose rosuvastatin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose rosuvastatin (10 mg/day)
Trial: 30661935
Drug: Experimental group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental group (n=12) receiving weekly 15- to 30-minute telephone dietary counseling stressing 2.5 cups per week CVs and 3.5 cups per week GLVs.
Trial: 30661935
Drug: Attention control
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Attention control group (n=12) receiving weekly 15- to 30-minute telephone dietary counseling focusing on general healthy eating for cancer survivors.
Trial: 21546436
Drug: Sildenafil 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 80 mg tid
Trial: 11557911
Drug: Morphine-d3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine-d3
Trial: 9226314
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily irradiation (2 Gy/day to 66-70 Gy) or twice daily irradiation (1.25 Gy B.I.D. to 70-75 Gy) +/− planned neck dissection (for ≥ N2A disease)
Trial: 3658552
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate (MgSO4), 6 mg elemental Mg/kg body weight, over 1 h
Trial: 8650966
Drug: Evidence-based medicine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based medicine approaches in medical education
Trial: 1348916
Drug: nebivolol 5
RxNorm normalized name: nebivolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nebivolol 5 mg once a day
Trial: 2946740
Drug: Nifedipine, 10
RxNorm normalized name: Nifedipine, 10 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine, 10 mg four times daily for 6 months
Trial: 2946740
Drug: Placebo four
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo four times daily for 6 months
Trial: 30355395
Drug: Cooked cauliflower
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooked cauliflower and cooked rice (CC+R)
Trial: 30355395
Drug: Homogenised counterparts
RxNorm normalized name: Counteract IB
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Homogenised counterparts of CE+R, CP+R, and CC+R
Trial: 27207511
Drug: Metreleptin treatment
RxNorm normalized name: Metreleptin
DrugBank: Metreleptin (DB09046)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metreleptin treatment
Trial: 14760126
Drug: Gemcitabine at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine at 100 mg/m2 or 50 mg/m2 concurrent with radiotherapy (70 Gy over 7 weeks)
Trial: 11704374
Drug: Inhaled carbon
RxNorm normalized name: carbon dioxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled carbon monoxide (CO) at 1,200 ppm to 1,500 ppm
Trial: 11704374
Drug: Inhaled air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled air
Trial: 8065190
Drug: Histamine type
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine type 2 receptor antagonists
Trial: 8065190
Drug: Promotility agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Promotility agents and surgical therapy
Trial: 26142341
Drug: Danlou Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danlou Tablet (4.5 g/day for 2 days before intervention, with a further 4.5 g/day for 90 days thereafter)
Trial: 26142341
Drug: Danlou Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danlou Tablet
Trial: 22105265
Drug: Nonoxynol-9 vaginal
RxNorm normalized name: nonoxynol-9 Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonoxynol-9 vaginal gel
Trial: 16005801
Drug: Chamfer preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chamfer preparation
Trial: 16005801
Drug: 135 degrees
RxNorm normalized name: NEEDLE 20G 1IN BENT 90 DEGREES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 135 degrees shoulder preparation
Trial: 16005801
Drug: 90 degrees
RxNorm normalized name: NEEDLE 22G 1IN BENT 90 DEGREES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 degrees shoulder preparation
Trial: 16005801
Drug: Gingival level
RxNorm normalized name: Bos taurus gingiva preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gingival level preparations
Trial: 8585970
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel blockers (including nifedipine, verapamil, cinnarizine, tetrandrine)
Trial: 204954
Drug: Exogenously administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exogenously administered oestrogens
Trial: 22435613
Drug: Aloe whole
RxNorm normalized name: Aloe arborescens whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aloe whole leaf extract (AL with vitamins B(12), 1 mg and vitamin C 500 mg)
Trial: 22435613
Drug: Aloe fillet
RxNorm normalized name: Aloe
DrugBank: Aloe ferox leaf (DB14257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aloe fillet gel (AG with B(12) 1 mg and vitamin C 500 mg)
Trial: 22435613
Drug: Water (with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water (with vitamin B(12) 1 mg and vitamin C 500 mg)
Trial: 19157139
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of traditional Chinese medicine (Changpikang) and ear acupoint therapy
Trial: 19157139
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine group (Changpikang)
Trial: 19157139
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (sulfasalazine)
Trial: 19157139
Drug: Medicine and
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicine and acupoint group (Changpikang and ear acupoint)
Trial: 16176505
Drug: Placebo (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (two lactose tablets rectally)
Trial: 12925933
Drug: Donepezil (acetylcholinesterase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (acetylcholinesterase inhibitor) for 12 weeks
Trial: 10820860
Drug: Budesonide foam
RxNorm normalized name: budesonide Rectal Foam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide foam (1 mg/50 ml b.i.d.)
Trial: 10820860
Drug: Mesalazine enemas
RxNorm normalized name: mesalamine Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalazine enemas (4 g/60 ml o.d.)
Trial: 8875971
Drug: Fluvastatin 20-40
RxNorm normalized name: fluvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20-40 mg/day
Trial: 8875971
Drug: Low-dose fluvastatin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose fluvastatin plus niacin
Trial: 8875971
Drug: Fluvastatin 20
RxNorm normalized name: fluvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20 or 40 mg/day
Trial: 29290052
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg of hydrocortisone
Trial: 25406552
Drug: Behavioral therapy
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral therapy plus oral flunarizine
Trial: 25406552
Drug: Oral flunarizine
RxNorm normalized name: flunarizine
DrugBank: Flunarizine (DB04841)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral flunarizine alone
Trial: 23098345
Drug: Prehospital aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prehospital aspirin
Trial: 23098345
Drug: Aspirin in
RxNorm normalized name: Non-Aspirin Infant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin in recommended initial dose (160-325 mg)
Trial: 16093252
Drug: Cognitive behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behaviour therapy plus 270 mg mebeverine taken thrice daily
Trial: 12625151
Drug: Pyrantel-oxantel (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyrantel-oxantel (10 mg/kg)
Trial: 12434648
Drug: Midodrine 10
RxNorm normalized name: midodrine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midodrine 10 mg per os